Codiak Biosciences Current Assets

Codiak Biosciences (CDAK) currently reports a current assets of $61M as of September 2022. That compares with $100M in the prior-year period — down 41.1% year over year. Use the charts on this page to explore Codiak Biosciences's current assets history and peer comparisons.

Codiak Biosciences's current assets decreased from $100M to $61M — a 41.1% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Codiak Biosciences reported $61M in current assets as of September 2022. That compares with $100M in the prior-year period — down 41.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Codiak Biosciences, and consider following CDAK for alerts when major investors trade the stock.

Codiak Biosciences is classified in the Healthcare sector. On current assets, it currently shows $61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDAK with unrelated industries.